ÂÜÀòÂÒÂ×

Chris Nishioka has a diverse work experience in the field of neuroscience and biomedical research. Chris started as a Research Assistant at the Seattle Institute for Biomedical and Clinical research in 2007. In 2008, they joined Elan Pharmaceuticals as a Research Associate II. Chris then worked as a Research Associate at Janssen Alzheimer Immunotherapy from 2009 to 2012. During this time, Chris developed skills in research methodology and data analysis.

In 2012, Chris joined the University of California, Riverside as a Neuroscience Graduate Student. Here, they gained valuable experience in developing in vivo disease models and testing therapeutic compounds for neurodegenerative diseases. Chris also worked on characterizing relationships between imaging and biomarkers of Alzheimer’s and Multiple Sclerosis, and neuron loss in the central nervous system. Chris gained expertise in animal model preparation, noninvasive imaging, and histology. Chris also served as a Graduate Teaching Assistant for psychology and neuroscience courses.

Starting in 2013, Chris became a Research Mentor at Loma Linda University Medical Center, where they shared their knowledge and mentored other researchers.

Most recently, Chris has been working as a Field Application Scientist at Molecular Devices since August 2019. In this role, they utilize their scientific expertise to assist customers with applications and technical support related to molecular devices and technologies.

Overall, Chris Nishioka's work experience demonstrates their commitment to neuroscience research and their ability to contribute to various aspects of the field, from conducting experiments and analyzing data to mentoring others and providing customer support.

Chris Nishioka completed a Doctor of Philosophy (Ph.D.) in Neuroscience from the University of California, Riverside, between 2012 and 2018. Prior to that, they obtained a Bachelor of Science (B.S.) degree in Molecular, Cellular and Developmental Biology from the University of Washington from 2004 to 2008.